Senseonics Holdings, Inc. (SENS) 10-Year Financial Performance & Capital Metrics

SENS • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

AboutSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Show more

Revenue $22M +0.4%
EBITDA -$73M +1.3%
Net Income -$79M -30.2%
EPS (Diluted) -2.50 -13.6%
Gross Margin 2.37% -82.8%
EBITDA Margin -326.48% +1.7%
Operating Margin -333.05% +1.4%
Net Margin -349.84% -29.7%
ROE -817.17% -124.8%
ROIC -
Debt/Equity -
Interest Coverage -8.87 -30.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 19 (bottom 19%)
✗Shares diluted 10.9% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y1.08%

3Y18.01%

TTM39.37%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM19.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM32.76%

ROCE

10Y Avg-282.43%

5Y Avg-172.31%

3Y Avg-60.2%

Latest-82%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DXCMDexCom, Inc.	27.68B	70.98	49.99	11.34%	15.96%	26.44%	2.28%	1.23
PODDInsulet Corporation	19.6B	278.55	48.19	22.07%	9.76%	17.79%	1.56%	1.17
AHCOAdaptHealth Corp.	1.44B	10.60	17.38	1.9%	2.81%	4.93%	16.43%	1.35
MODDModular Medical, Inc.	36.9M	0.48	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	290.5M	7.11	-2.84	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.45B	21.35	-14.52	25.74%	-20.2%	-152.95%	0.34%	1.80

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	38K	332K	6.37M	18.91M	21.3M	4.95M	13.68M	16.39M	22.39M	22.47M
Revenue Growth %	-	7.74%	18.2%	1.97%	0.13%	-0.77%	1.76%	0.2%	0.37%	0%
Cost of Goods Sold+	0	660K	9.76M	27.06M	40.75M	22.32M	14.49M	13.66M	19.3M	21.94M
COGS % of Revenue	-	1.99%	1.53%	1.43%	1.91%	4.51%	1.06%	0.83%	0.86%	0.98%
Gross Profit+	-80K	-328K	-3.38M	-8.15M	-19.45M	-17.37M	-811K	2.73M	3.09M	533K
Gross Margin %	-2.11%	-0.99%	-0.53%	-0.43%	-0.91%	-3.51%	-0.06%	0.17%	0.14%	0.02%
Gross Profit Growth %	-	-3.1%	-9.32%	-1.41%	-1.39%	0.11%	0.95%	4.36%	0.13%	-0.83%
Operating Expenses+	28.85M	42.1M	52.93M	79.43M	111.21M	61.76M	56.37M	71.35M	78.69M	75.38M
OpEx % of Revenue	759.21%	126.82%	8.31%	4.2%	5.22%	12.48%	4.12%	4.35%	3.51%	3.35%
Selling, General & Admin	10.6M	15.76M	22.19M	47.57M	72.78M	41.35M	29.15M	31.63M	29.94M	34.23M
SG&A % of Revenue	278.92%	47.46%	3.48%	2.52%	3.42%	8.36%	2.13%	1.93%	1.34%	1.52%
Research & Development	18.25M	26.35M	30.73M	31.86M	38.43M	20.41M	27.22M	39.72M	48.75M	41.14M
R&D % of Revenue	480.29%	79.36%	4.82%	1.68%	1.8%	4.12%	1.99%	2.42%	2.18%	1.83%
Other Operating Expenses	0	25K	176K	-321K	0	0	0	0	0	0
Operating Income+	-28.81M	-42.43M	-56.31M	-87.58M	-130.66M	-79.13M	-57.18M	-68.63M	-75.6M	-74.84M
Operating Margin %	-758.21%	-127.81%	-8.84%	-4.63%	-6.13%	-15.99%	-4.18%	-4.19%	-3.38%	-3.33%
Operating Income Growth %	-0.54%	-0.47%	-0.33%	-0.56%	-0.49%	0.39%	0.28%	-0.2%	-0.1%	0.01%
EBITDA+	-28.69M	-42.28M	-56.09M	-87.31M	-129.66M	-77.99M	-55.94M	-67.64M	-74.33M	-73.37M
EBITDA Margin %	-755.11%	-127.34%	-8.8%	-4.62%	-6.09%	-15.76%	-4.09%	-4.13%	-3.32%	-3.26%
EBITDA Growth %	-0.55%	-0.47%	-0.33%	-0.56%	-0.49%	0.4%	0.28%	-0.21%	-0.1%	0.01%
D&A (Non-Cash Add-back)	118K	155K	227.27K	270K	1M	1.14M	1.24M	985K	1.28M	1.48M
EBIT	-28.78M	-42.33M	-56M	-85.69M	-100.41M	-159M	-285.75M	160.82M	-49.28M	-70.18M
Net Interest Income+	-1.09M	-1.52M	-2.96M	-6.28M	-13.21M	-15.99M	-16.48M	-16.88M	-5.75M	-3.94M
Interest Income	9K	80K	135K	2M	1.93M	175K	243K	1.82M	5.36M	4.5M
Interest Expense	1.1M	1.6M	3.1M	8.28M	15.14M	16.17M	16.72M	18.7M	11.11M	8.44M
Other Income/Expense	-1.06M	-1.5M	-2.79M	-6.39M	15.11M	-96.04M	-245.29M	210.75M	15.21M	-3.77M
Pretax Income+	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Pretax Margin %	-786.24%	-132.32%	-9.27%	-4.97%	-5.42%	-35.39%	-22.12%	8.67%	-2.7%	-3.5%
Income Tax+	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Net Margin %	-786.24%	-132.32%	-9.27%	-4.97%	-5.42%	-35.39%	-22.12%	8.67%	-2.7%	-3.5%
Net Income Growth %	-0.58%	-0.47%	-0.35%	-0.59%	-0.23%	-0.52%	-0.73%	1.47%	-1.42%	-0.3%
Net Income (Continuing)	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-6.60	-9.80	-10.20	-12.00	-12.20	-15.40	-14.40	-2.20	-2.20	-2.50
EPS Growth %	-0.57%	-0.48%	-0.04%	-0.18%	-0.02%	-0.26%	0.06%	0.85%	0%	-0.14%
EPS (Basic)	-6.60	-9.80	-10.20	-12.00	-12.20	-15.40	-14.40	6.00	-2.20	-2.50
Diluted Shares Outstanding	4.58M	4.46M	5.8M	7.87M	9.44M	11.4M	21.12M	30.91M	28.4M	31.49M
Basic Shares Outstanding	4.58M	4.46M	5.8M	7.87M	9.44M	11.4M	21.12M	23.4M	28.4M	31.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.96M	21.43M	44.91M	158.11M	127.76M	30.25M	144.41M	161.2M	130.03M	91.44M
Cash & Short-Term Investments	3.94M	20.34M	36.45M	136.79M	95.94M	18M	129.91M	144.01M	109.46M	74.6M
Cash Only	3.94M	13.05M	16.15M	136.79M	95.94M	18M	33.46M	35.79M	75.71M	74.6M
Short-Term Investments	0	7.29M	20.3M	0	0	0	96.44M	108.22M	33.75M	0
Accounts Receivable	0	251K	3.39M	7.1M	10.49M	2.99M	2.42M	2.79M	6.6M	8.08M
Days Sales Outstanding	-	275.95	193.93	136.96	179.68	220.22	64.49	62.07	107.54	131.22
Inventory	0	477K	2.99M	10.23M	16.93M	5.28M	6.32M	7.31M	8.78M	4.42M
Days Inventory Outstanding	-	263.8	111.88	138.01	151.64	86.38	159.14	195.18	165.98	73.55
Other Current Assets	1.02M	365K	48K	142K	179K	200K	56K	12K	1K	333K
Total Non-Current Assets+	528K	840K	1.03M	1.87M	5.04M	5.67M	54.52M	16.47M	8.19M	9M
Property, Plant & Equipment	311K	735K	853K	1.75M	2M	1.56M	1.31M	1.11M	1.18M	3.59M
Fixed Asset Turnover	0.12x	0.45x	7.47x	10.81x	10.65x	3.18x	10.45x	14.74x	18.91x	6.26x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	481.92K
Long-Term Investments	0	0	0	0	0	0	51.88M	12.25M	0	0
Other Non-Current Assets	217K	105K	176K	117K	3.04M	4.12M	1.32M	3.11M	7.01M	4.93M
Total Assets+	5.49M	22.27M	45.94M	159.97M	132.8M	35.92M	198.93M	177.67M	138.22M	100.44M
Asset Turnover	0.01x	0.01x	0.14x	0.12x	0.16x	0.14x	0.07x	0.09x	0.16x	0.22x
Asset Growth %	-0.73%	3.06%	1.06%	2.48%	-0.17%	-0.73%	4.54%	-0.11%	-0.22%	-0.27%
Total Current Liabilities+	7.33M	11.63M	23.14M	28.89M	126.71M	16.64M	18.39M	31.47M	17.26M	38.85M
Accounts Payable	1.25M	3.07M	7.71M	4.41M	4.29M	1.76M	1.2M	419K	4.57M	3.21M
Days Payables Outstanding	-	1.7K	288.47	59.45	38.38	28.82	30.34	11.19	86.39	53.32
Short-Term Debt	2.39M	3.89M	10M	10M	103.79M	3.2M	2.93M	15.58M	0	20.14M
Deferred Revenue (Current)	1000K	1000K	1000K	628K	0	0	0	0	0	0
Other Current Liabilities	3.09M	2.86M	3.22M	10.17M	7.86M	5.14M	-904K	5.51M	5.34M	5.79M
Current Ratio	0.68x	1.84x	1.94x	5.47x	1.01x	1.82x	7.85x	5.12x	7.53x	2.35x
Quick Ratio	0.68x	1.80x	1.81x	5.12x	0.87x	1.50x	7.51x	4.89x	7.03x	2.24x
Cash Conversion Cycle	-	-1.16K	17.34	215.52	292.94	277.78	193.29	246.05	187.13	151.45
Total Non-Current Liabilities+	7.85M	15.52M	15.54M	59.83M	14.74M	163.36M	366.07M	148.78M	85.17M	78.14M
Long-Term Debt	7.43M	15.18M	14.41M	40.97M	11.8M	57.22M	59.8M	56.38M	41.2M	34.7M
Capital Lease Obligations	0	73K	69K	0	2.28M	1.48M	579K	2.69M	6.21M	5.79M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	355K	273K	1.05M	18.86M	664K	104.66M	305.69M	89.71M	37.76M	37.66M
Total Liabilities	15.19M	27.15M	38.68M	88.71M	141.45M	180M	384.46M	180.25M	102.42M	116.99M
Total Debt+	9.89M	19.22M	24.48M	50.97M	118.56M	62.7M	64.21M	75.38M	47.78M	61.05M
Net Debt	5.95M	6.17M	8.33M	-85.82M	22.62M	44.69M	30.75M	39.58M	-27.93M	-13.54M
Debt / Equity	-	-	3.37x	0.72x	-	-	-	-	1.33x	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-26.19x	-26.49x	-18.17x	-10.57x	-8.63x	-4.89x	-3.42x	-3.67x	-6.80x	-8.87x
Total Equity+	-9.7M	-4.88M	7.27M	71.26M	-8.65M	-144.08M	-185.53M	-2.58M	35.8M	-16.55M
Equity Growth %	-2.23%	0.5%	2.49%	8.81%	-1.12%	-15.66%	-0.29%	0.99%	14.9%	-1.46%
Book Value per Share	-2.12	-1.09	1.25	9.05	-0.92	-12.64	-8.79	-0.08	1.26	-0.53
Total Shareholders' Equity	-9.7M	-4.88M	7.27M	71.26M	-8.65M	-144.08M	-185.53M	-2.58M	35.8M	-16.55M
Common Stock	76K	94K	137K	177K	203K	266K	447K	480K	530K	595K
Retained Earnings	-160.79M	-204.72M	-263.82M	-357.79M	-473.34M	-648.51M	-950.99M	-808.87M	-869.26M	-947.87M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	-813K	-1.04M	-1.31M	0	0	-212K	-678K	-11K	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-25.46M	-38.02M	-55.74M	-90.77M	-136.05M	-67.42M	-56.08M	-66.31M	-70.16M	-60.47M
Operating CF Margin %	-670.13%	-114.51%	-8.75%	-4.8%	-6.39%	-13.62%	-4.1%	-4.05%	-3.13%	-2.69%
Operating CF Growth %	-0.32%	-0.49%	-0.47%	-0.63%	-0.5%	0.5%	0.17%	-0.18%	-0.06%	0.14%
Net Income	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Depreciation & Amortization	118K	155K	227K	270K	1M	1.14M	1.24M	985K	1.28M	1.48M
Stock-Based Compensation	1.43M	2.42M	3.99M	6.41M	8.05M	7.31M	9.03M	8.62M	8.67M	9.22M
Deferred Taxes	-46K	430K	98K	-123K	0	61.82M	229.17M	0	0	0
Other Non-Cash Items	77K	252K	453K	3.32M	-20.07M	23.68M	8.46M	-215.56M	-15.76M	6.59M
Working Capital Changes	2.83M	2.66M	-1.41M	-6.68M	-9.48M	13.79M	-1.5M	-2.47M	-3.97M	865K
Change in Receivables	0	-250K	-3.13M	-3.71M	-3.28M	7.39M	1.01M	-478K	-2.19M	-2.7M
Change in Inventory	0	-477K	-2.74M	-7.44M	-6.7M	15.82M	-1.04M	-989K	-1.64M	696K
Change in Payables	3.23M	1.82M	4.64M	-3.4M	-122K	-2.52M	-559K	-785K	2.3M	-1.83M
Cash from Investing+	-202K	-7.77M	-13.23M	19.43M	-1.04M	-181K	-148.75M	26.88M	89.71M	32.84M
Capital Expenditures	-202K	-479K	-345K	-989K	-1.04M	-181K	-210K	-312K	-350K	-2.24M
CapEx % of Revenue	5.32%	1.44%	0.05%	0.05%	0.05%	0.04%	0.02%	0.02%	0.02%	0.1%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-7.29M	-12.88M	20.41M	0	0	-210K	27.19M	0	0
Cash from Financing+	10.68M	54.89M	72.07M	191.99M	96.24M	-10.13M	220.08M	41.76M	20.37M	26.83M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	62K	-1.29M	-408K	14K	-3.47M	-601K	-227K	-1.49M	11.74M	-1.48M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-25.67M	-38.49M	-56.08M	-91.76M	-137.09M	-67.6M	-56.29M	-66.62M	-70.51M	-62.7M
FCF Margin %	-675.45%	-115.95%	-8.8%	-4.85%	-6.44%	-13.66%	-4.12%	-4.07%	-3.15%	-2.79%
FCF Growth %	-0.33%	-0.5%	-0.46%	-0.64%	-0.49%	0.51%	0.17%	-0.18%	-0.06%	0.11%
FCF per Share	-5.61	-8.63	-9.67	-11.66	-14.53	-5.93	-2.67	-2.16	-2.48	-1.99
FCF Conversion (FCF/Net Income)	0.85x	0.87x	0.94x	0.97x	1.18x	0.38x	0.19x	-0.47x	1.16x	0.77x
Interest Paid	0	0	0	0	5.23M	0	0	0	0	4.51M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-4945.69%	-239.33%	-369.1%	-	-	-	-363.59%	-817.17%
Return on Invested Capital (ROIC)	-	-	-500%	-12643.6%	-	-	-	-	-252.73%	-
Gross Margin	-210.53%	-98.8%	-53.11%	-43.07%	-91.3%	-350.9%	-5.93%	16.63%	13.81%	2.37%
Net Margin	-78623.68%	-13231.93%	-927.37%	-496.86%	-542.46%	-3539.46%	-2211.88%	867.16%	-269.73%	-349.84%
Debt / Equity	-	-	3.37x	0.72x	-	-	-	-	1.33x	-
Interest Coverage	-26.19x	-26.49x	-18.17x	-10.57x	-8.63x	-4.89x	-3.42x	-3.67x	-6.80x	-8.87x
FCF Conversion	0.85x	0.87x	0.94x	0.97x	1.18x	0.38x	0.19x	-0.47x	1.16x	0.77x
Revenue Growth	-	773.68%	1819.58%	196.77%	12.63%	-76.77%	176.32%	19.85%	36.62%	0.37%

Revenue by Geography

	2022	2023	2024
UNITED STATES	-	-	15.28M
UNITED STATES Growth	-	-	-
United States	7.51M	8.34M	-
United States Growth	-	10.98%	-

Frequently Asked Questions

Growth & Financials

Senseonics Holdings, Inc. (SENS) reported $30.9M in revenue for fiscal year 2024. This represents a 181935% increase from $0.0M in 2013.

Senseonics Holdings, Inc. (SENS) grew revenue by 0.4% over the past year. Growth has been modest.

Senseonics Holdings, Inc. (SENS) reported a net loss of $64.7M for fiscal year 2024.

Dividend & Returns

Senseonics Holdings, Inc. (SENS) has a return on equity (ROE) of -817.2%. Negative ROE indicates the company is unprofitable.

Senseonics Holdings, Inc. (SENS) had negative free cash flow of $56.2M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Senseonics Holdings, Inc. (SENS) 10-Year Financial Performance & Capital Metrics

SENS • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

Revenue $22M +0.4%
EBITDA -$73M +1.3%
Net Income -$79M -30.2%
EPS (Diluted) -2.50 -13.6%
Gross Margin 2.37% -82.8%
EBITDA Margin -326.48% +1.7%
Operating Margin -333.05% +1.4%
Net Margin -349.84% -29.7%
ROE -817.17% -124.8%
ROIC -
Debt/Equity -
Interest Coverage -8.87 -30.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 19 (bottom 19%)
✗Shares diluted 10.9% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y1.08%

3Y18.01%

TTM39.37%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM19.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM32.76%

ROCE

10Y Avg-282.43%

5Y Avg-172.31%

3Y Avg-60.2%

Latest-82%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DXCMDexCom, Inc.	27.68B	70.98	49.99	11.34%	15.96%	26.44%	2.28%	1.23
PODDInsulet Corporation	19.6B	278.55	48.19	22.07%	9.76%	17.79%	1.56%	1.17
AHCOAdaptHealth Corp.	1.44B	10.60	17.38	1.9%	2.81%	4.93%	16.43%	1.35
MODDModular Medical, Inc.	36.9M	0.48	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	290.5M	7.11	-2.84	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.45B	21.35	-14.52	25.74%	-20.2%	-152.95%	0.34%	1.80

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	38K	332K	6.37M	18.91M	21.3M	4.95M	13.68M	16.39M	22.39M	22.47M
Revenue Growth %	-	7.74%	18.2%	1.97%	0.13%	-0.77%	1.76%	0.2%	0.37%	0%
Cost of Goods Sold+	0	660K	9.76M	27.06M	40.75M	22.32M	14.49M	13.66M	19.3M	21.94M
COGS % of Revenue	-	1.99%	1.53%	1.43%	1.91%	4.51%	1.06%	0.83%	0.86%	0.98%
Gross Profit+	-80K	-328K	-3.38M	-8.15M	-19.45M	-17.37M	-811K	2.73M	3.09M	533K
Gross Margin %	-2.11%	-0.99%	-0.53%	-0.43%	-0.91%	-3.51%	-0.06%	0.17%	0.14%	0.02%
Gross Profit Growth %	-	-3.1%	-9.32%	-1.41%	-1.39%	0.11%	0.95%	4.36%	0.13%	-0.83%
Operating Expenses+	28.85M	42.1M	52.93M	79.43M	111.21M	61.76M	56.37M	71.35M	78.69M	75.38M
OpEx % of Revenue	759.21%	126.82%	8.31%	4.2%	5.22%	12.48%	4.12%	4.35%	3.51%	3.35%
Selling, General & Admin	10.6M	15.76M	22.19M	47.57M	72.78M	41.35M	29.15M	31.63M	29.94M	34.23M
SG&A % of Revenue	278.92%	47.46%	3.48%	2.52%	3.42%	8.36%	2.13%	1.93%	1.34%	1.52%
Research & Development	18.25M	26.35M	30.73M	31.86M	38.43M	20.41M	27.22M	39.72M	48.75M	41.14M
R&D % of Revenue	480.29%	79.36%	4.82%	1.68%	1.8%	4.12%	1.99%	2.42%	2.18%	1.83%
Other Operating Expenses	0	25K	176K	-321K	0	0	0	0	0	0
Operating Income+	-28.81M	-42.43M	-56.31M	-87.58M	-130.66M	-79.13M	-57.18M	-68.63M	-75.6M	-74.84M
Operating Margin %	-758.21%	-127.81%	-8.84%	-4.63%	-6.13%	-15.99%	-4.18%	-4.19%	-3.38%	-3.33%
Operating Income Growth %	-0.54%	-0.47%	-0.33%	-0.56%	-0.49%	0.39%	0.28%	-0.2%	-0.1%	0.01%
EBITDA+	-28.69M	-42.28M	-56.09M	-87.31M	-129.66M	-77.99M	-55.94M	-67.64M	-74.33M	-73.37M
EBITDA Margin %	-755.11%	-127.34%	-8.8%	-4.62%	-6.09%	-15.76%	-4.09%	-4.13%	-3.32%	-3.26%
EBITDA Growth %	-0.55%	-0.47%	-0.33%	-0.56%	-0.49%	0.4%	0.28%	-0.21%	-0.1%	0.01%
D&A (Non-Cash Add-back)	118K	155K	227.27K	270K	1M	1.14M	1.24M	985K	1.28M	1.48M
EBIT	-28.78M	-42.33M	-56M	-85.69M	-100.41M	-159M	-285.75M	160.82M	-49.28M	-70.18M
Net Interest Income+	-1.09M	-1.52M	-2.96M	-6.28M	-13.21M	-15.99M	-16.48M	-16.88M	-5.75M	-3.94M
Interest Income	9K	80K	135K	2M	1.93M	175K	243K	1.82M	5.36M	4.5M
Interest Expense	1.1M	1.6M	3.1M	8.28M	15.14M	16.17M	16.72M	18.7M	11.11M	8.44M
Other Income/Expense	-1.06M	-1.5M	-2.79M	-6.39M	15.11M	-96.04M	-245.29M	210.75M	15.21M	-3.77M
Pretax Income+	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Pretax Margin %	-786.24%	-132.32%	-9.27%	-4.97%	-5.42%	-35.39%	-22.12%	8.67%	-2.7%	-3.5%
Income Tax+	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Net Margin %	-786.24%	-132.32%	-9.27%	-4.97%	-5.42%	-35.39%	-22.12%	8.67%	-2.7%	-3.5%
Net Income Growth %	-0.58%	-0.47%	-0.35%	-0.59%	-0.23%	-0.52%	-0.73%	1.47%	-1.42%	-0.3%
Net Income (Continuing)	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-6.60	-9.80	-10.20	-12.00	-12.20	-15.40	-14.40	-2.20	-2.20	-2.50
EPS Growth %	-0.57%	-0.48%	-0.04%	-0.18%	-0.02%	-0.26%	0.06%	0.85%	0%	-0.14%
EPS (Basic)	-6.60	-9.80	-10.20	-12.00	-12.20	-15.40	-14.40	6.00	-2.20	-2.50
Diluted Shares Outstanding	4.58M	4.46M	5.8M	7.87M	9.44M	11.4M	21.12M	30.91M	28.4M	31.49M
Basic Shares Outstanding	4.58M	4.46M	5.8M	7.87M	9.44M	11.4M	21.12M	23.4M	28.4M	31.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.96M	21.43M	44.91M	158.11M	127.76M	30.25M	144.41M	161.2M	130.03M	91.44M
Cash & Short-Term Investments	3.94M	20.34M	36.45M	136.79M	95.94M	18M	129.91M	144.01M	109.46M	74.6M
Cash Only	3.94M	13.05M	16.15M	136.79M	95.94M	18M	33.46M	35.79M	75.71M	74.6M
Short-Term Investments	0	7.29M	20.3M	0	0	0	96.44M	108.22M	33.75M	0
Accounts Receivable	0	251K	3.39M	7.1M	10.49M	2.99M	2.42M	2.79M	6.6M	8.08M
Days Sales Outstanding	-	275.95	193.93	136.96	179.68	220.22	64.49	62.07	107.54	131.22
Inventory	0	477K	2.99M	10.23M	16.93M	5.28M	6.32M	7.31M	8.78M	4.42M
Days Inventory Outstanding	-	263.8	111.88	138.01	151.64	86.38	159.14	195.18	165.98	73.55
Other Current Assets	1.02M	365K	48K	142K	179K	200K	56K	12K	1K	333K
Total Non-Current Assets+	528K	840K	1.03M	1.87M	5.04M	5.67M	54.52M	16.47M	8.19M	9M
Property, Plant & Equipment	311K	735K	853K	1.75M	2M	1.56M	1.31M	1.11M	1.18M	3.59M
Fixed Asset Turnover	0.12x	0.45x	7.47x	10.81x	10.65x	3.18x	10.45x	14.74x	18.91x	6.26x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	481.92K
Long-Term Investments	0	0	0	0	0	0	51.88M	12.25M	0	0
Other Non-Current Assets	217K	105K	176K	117K	3.04M	4.12M	1.32M	3.11M	7.01M	4.93M
Total Assets+	5.49M	22.27M	45.94M	159.97M	132.8M	35.92M	198.93M	177.67M	138.22M	100.44M
Asset Turnover	0.01x	0.01x	0.14x	0.12x	0.16x	0.14x	0.07x	0.09x	0.16x	0.22x
Asset Growth %	-0.73%	3.06%	1.06%	2.48%	-0.17%	-0.73%	4.54%	-0.11%	-0.22%	-0.27%
Total Current Liabilities+	7.33M	11.63M	23.14M	28.89M	126.71M	16.64M	18.39M	31.47M	17.26M	38.85M
Accounts Payable	1.25M	3.07M	7.71M	4.41M	4.29M	1.76M	1.2M	419K	4.57M	3.21M
Days Payables Outstanding	-	1.7K	288.47	59.45	38.38	28.82	30.34	11.19	86.39	53.32
Short-Term Debt	2.39M	3.89M	10M	10M	103.79M	3.2M	2.93M	15.58M	0	20.14M
Deferred Revenue (Current)	1000K	1000K	1000K	628K	0	0	0	0	0	0
Other Current Liabilities	3.09M	2.86M	3.22M	10.17M	7.86M	5.14M	-904K	5.51M	5.34M	5.79M
Current Ratio	0.68x	1.84x	1.94x	5.47x	1.01x	1.82x	7.85x	5.12x	7.53x	2.35x
Quick Ratio	0.68x	1.80x	1.81x	5.12x	0.87x	1.50x	7.51x	4.89x	7.03x	2.24x
Cash Conversion Cycle	-	-1.16K	17.34	215.52	292.94	277.78	193.29	246.05	187.13	151.45
Total Non-Current Liabilities+	7.85M	15.52M	15.54M	59.83M	14.74M	163.36M	366.07M	148.78M	85.17M	78.14M
Long-Term Debt	7.43M	15.18M	14.41M	40.97M	11.8M	57.22M	59.8M	56.38M	41.2M	34.7M
Capital Lease Obligations	0	73K	69K	0	2.28M	1.48M	579K	2.69M	6.21M	5.79M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	355K	273K	1.05M	18.86M	664K	104.66M	305.69M	89.71M	37.76M	37.66M
Total Liabilities	15.19M	27.15M	38.68M	88.71M	141.45M	180M	384.46M	180.25M	102.42M	116.99M
Total Debt+	9.89M	19.22M	24.48M	50.97M	118.56M	62.7M	64.21M	75.38M	47.78M	61.05M
Net Debt	5.95M	6.17M	8.33M	-85.82M	22.62M	44.69M	30.75M	39.58M	-27.93M	-13.54M
Debt / Equity	-	-	3.37x	0.72x	-	-	-	-	1.33x	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-26.19x	-26.49x	-18.17x	-10.57x	-8.63x	-4.89x	-3.42x	-3.67x	-6.80x	-8.87x
Total Equity+	-9.7M	-4.88M	7.27M	71.26M	-8.65M	-144.08M	-185.53M	-2.58M	35.8M	-16.55M
Equity Growth %	-2.23%	0.5%	2.49%	8.81%	-1.12%	-15.66%	-0.29%	0.99%	14.9%	-1.46%
Book Value per Share	-2.12	-1.09	1.25	9.05	-0.92	-12.64	-8.79	-0.08	1.26	-0.53
Total Shareholders' Equity	-9.7M	-4.88M	7.27M	71.26M	-8.65M	-144.08M	-185.53M	-2.58M	35.8M	-16.55M
Common Stock	76K	94K	137K	177K	203K	266K	447K	480K	530K	595K
Retained Earnings	-160.79M	-204.72M	-263.82M	-357.79M	-473.34M	-648.51M	-950.99M	-808.87M	-869.26M	-947.87M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	-813K	-1.04M	-1.31M	0	0	-212K	-678K	-11K	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-25.46M	-38.02M	-55.74M	-90.77M	-136.05M	-67.42M	-56.08M	-66.31M	-70.16M	-60.47M
Operating CF Margin %	-670.13%	-114.51%	-8.75%	-4.8%	-6.39%	-13.62%	-4.1%	-4.05%	-3.13%	-2.69%
Operating CF Growth %	-0.32%	-0.49%	-0.47%	-0.63%	-0.5%	0.5%	0.17%	-0.18%	-0.06%	0.14%
Net Income	-29.88M	-43.93M	-59.1M	-93.97M	-115.55M	-175.17M	-302.47M	142.12M	-60.39M	-78.62M
Depreciation & Amortization	118K	155K	227K	270K	1M	1.14M	1.24M	985K	1.28M	1.48M
Stock-Based Compensation	1.43M	2.42M	3.99M	6.41M	8.05M	7.31M	9.03M	8.62M	8.67M	9.22M
Deferred Taxes	-46K	430K	98K	-123K	0	61.82M	229.17M	0	0	0
Other Non-Cash Items	77K	252K	453K	3.32M	-20.07M	23.68M	8.46M	-215.56M	-15.76M	6.59M
Working Capital Changes	2.83M	2.66M	-1.41M	-6.68M	-9.48M	13.79M	-1.5M	-2.47M	-3.97M	865K
Change in Receivables	0	-250K	-3.13M	-3.71M	-3.28M	7.39M	1.01M	-478K	-2.19M	-2.7M
Change in Inventory	0	-477K	-2.74M	-7.44M	-6.7M	15.82M	-1.04M	-989K	-1.64M	696K
Change in Payables	3.23M	1.82M	4.64M	-3.4M	-122K	-2.52M	-559K	-785K	2.3M	-1.83M
Cash from Investing+	-202K	-7.77M	-13.23M	19.43M	-1.04M	-181K	-148.75M	26.88M	89.71M	32.84M
Capital Expenditures	-202K	-479K	-345K	-989K	-1.04M	-181K	-210K	-312K	-350K	-2.24M
CapEx % of Revenue	5.32%	1.44%	0.05%	0.05%	0.05%	0.04%	0.02%	0.02%	0.02%	0.1%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-7.29M	-12.88M	20.41M	0	0	-210K	27.19M	0	0
Cash from Financing+	10.68M	54.89M	72.07M	191.99M	96.24M	-10.13M	220.08M	41.76M	20.37M	26.83M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	62K	-1.29M	-408K	14K	-3.47M	-601K	-227K	-1.49M	11.74M	-1.48M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-25.67M	-38.49M	-56.08M	-91.76M	-137.09M	-67.6M	-56.29M	-66.62M	-70.51M	-62.7M
FCF Margin %	-675.45%	-115.95%	-8.8%	-4.85%	-6.44%	-13.66%	-4.12%	-4.07%	-3.15%	-2.79%
FCF Growth %	-0.33%	-0.5%	-0.46%	-0.64%	-0.49%	0.51%	0.17%	-0.18%	-0.06%	0.11%
FCF per Share	-5.61	-8.63	-9.67	-11.66	-14.53	-5.93	-2.67	-2.16	-2.48	-1.99
FCF Conversion (FCF/Net Income)	0.85x	0.87x	0.94x	0.97x	1.18x	0.38x	0.19x	-0.47x	1.16x	0.77x
Interest Paid	0	0	0	0	5.23M	0	0	0	0	4.51M
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-4945.69%	-239.33%	-369.1%	-	-	-	-363.59%	-817.17%
Return on Invested Capital (ROIC)	-	-	-500%	-12643.6%	-	-	-	-	-252.73%	-
Gross Margin	-210.53%	-98.8%	-53.11%	-43.07%	-91.3%	-350.9%	-5.93%	16.63%	13.81%	2.37%
Net Margin	-78623.68%	-13231.93%	-927.37%	-496.86%	-542.46%	-3539.46%	-2211.88%	867.16%	-269.73%	-349.84%
Debt / Equity	-	-	3.37x	0.72x	-	-	-	-	1.33x	-
Interest Coverage	-26.19x	-26.49x	-18.17x	-10.57x	-8.63x	-4.89x	-3.42x	-3.67x	-6.80x	-8.87x
FCF Conversion	0.85x	0.87x	0.94x	0.97x	1.18x	0.38x	0.19x	-0.47x	1.16x	0.77x
Revenue Growth	-	773.68%	1819.58%	196.77%	12.63%	-76.77%	176.32%	19.85%	36.62%	0.37%

Revenue by Geography

	2022	2023	2024
UNITED STATES	-	-	15.28M
UNITED STATES Growth	-	-	-
United States	7.51M	8.34M	-
United States Growth	-	10.98%	-

Frequently Asked Questions

Growth & Financials

Senseonics Holdings, Inc. (SENS) reported $30.9M in revenue for fiscal year 2024. This represents a 181935% increase from $0.0M in 2013.

Senseonics Holdings, Inc. (SENS) grew revenue by 0.4% over the past year. Growth has been modest.

Senseonics Holdings, Inc. (SENS) reported a net loss of $64.7M for fiscal year 2024.

Dividend & Returns

Senseonics Holdings, Inc. (SENS) has a return on equity (ROE) of -817.2%. Negative ROE indicates the company is unprofitable.

Senseonics Holdings, Inc. (SENS) had negative free cash flow of $56.2M in fiscal year 2024, likely due to heavy capital investments.